PARAMETERS CONTROLLING THE PROGRAMMED DEATH OF MATURE MOUSE T-LYMPHOCYTES IN HIGH-DOSE SUPPRESSION

被引:35
作者
CRITCHFIELD, JM [1 ]
ZUNIGAPFLUCKER, JC [1 ]
LENARDO, MJ [1 ]
机构
[1] NIAID,IMMUNOL LAB,BETHESDA,MD 20892
关键词
D O I
10.1016/0008-8749(95)80011-7
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We have characterized parameters of both T cells and antigen-presenting cells (APCs) that influence high-dose suppression due to apoptosis. Blockade of interleukin-2 (IL-2) utilization is shown to inhibit both proliferation and the ensuing death. An analysis of sublines of a mature T cell clone demonstrates a correlation between IL-2 receptor cr chain (IL-BR) induction, increased proliferation, and greater suppression at high antigen doses. Profound loss of cells at high antigen dose was found to require at least 48 to 72 hr to develop. Antigen add-back experiments showed that strong T cell receptor reengagement of activated, cycling cells was essential for proliferative suppression and cell loss. Increasing the ratio of APC:T lymphocytes to 50:1 augmented cell death. For antigen-induced death of lymph node T cells, fresh T-depleted splenocytes were more effective than splenocytes that had been irradiated or treated with mitomycin C. Thus, T lymphocyte apoptosis at high antigen doses is a function of the activation response of the T lymphocyte as well as the efficiency of antigen presentation by the APC. These results strengthen the theory that apoptosis takes part in a feedback regulatory mechanism that has been called propricoidal regulation, which limits T cell expansion at high antigen doses. (C) 1995 Academic Press, Inc.
引用
收藏
页码:71 / 78
页数:8
相关论文
共 26 条
[1]   PROPRIOCIDAL APOPTOSIS OF MATURE T-LYMPHOCYTES OCCURS AT S-PHASE OF THE CELL-CYCLE [J].
BOEHME, SA ;
LENARDO, MJ .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (07) :1552-1560
[2]  
BOEHME SA, 1993, LEUKEMIA, V2, pS45
[3]   T-CELL DELETION IN HIGH ANTIGEN DOSE THERAPY OF AUTOIMMUNE ENCEPHALOMYELITIS [J].
CRITCHFIELD, JM ;
RACKE, MK ;
ZUNIGAPFLUCKER, JC ;
CANNELLA, B ;
RAINE, CS ;
GOVERMAN, J ;
LENARDO, MJ .
SCIENCE, 1994, 263 (5150) :1139-1143
[4]  
CRITCHFIELD JM, 1994, APOPTOSIS IMMUNE RES
[5]  
ETTINGER R, 1994, J IMMUNOL, V152, P1557
[6]  
GILLETTEFERGUSO.I, 1994, EUR J IMMUNOL, V24, P1181
[7]   TRANSGENIC MICE THAT EXPRESS A MYELIN BASIC PROTEIN-SPECIFIC T-CELL RECEPTOR DEVELOP SPONTANEOUS AUTOIMMUNITY [J].
GOVERMAN, J ;
WOODS, A ;
LARSON, L ;
WEINER, LP ;
HOOD, L ;
ZALLER, DM .
CELL, 1993, 72 (04) :551-560
[8]  
HECHT TT, 1983, J IMMUNOL, V131, P1049
[9]  
JANSSEN O, 1991, J IMMUNOL, V146, P35
[10]   TRANSACTIVATION BY AP-1 IS A MOLECULAR TARGET OF T-CELL CLONAL ANERGY [J].
KANG, SM ;
BEVERLY, B ;
TRAN, AC ;
BRORSON, K ;
SCHWARTZ, RH ;
LENARDO, MJ .
SCIENCE, 1992, 257 (5073) :1134-1138